{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:45:52Z","timestamp":1772120752612,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejogrb.2025.114663","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:28:06Z","timestamp":1755617286000},"page":"114663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The influence of serum luteinising hormone concentrations post GnRH agonist trigger on metaphase II oocytes in IVF\/ICSI cycles"],"prefix":"10.1016","volume":"314","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1483-1492","authenticated-orcid":false,"given":"Shital","family":"Sawant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasha","family":"Tulsyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Homburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2025.114663_b0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114663_b0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/oxfordjournals.humrep.a138097","article-title":"The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles","volume":"8","author":"Check","year":"1993","journal-title":"Hum Reprod"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114663_b0015","first-page":"557","article-title":"GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF\/ICSI cycles: a review article","volume":"14","author":"Alyasin","year":"2016","journal-title":"Int J Reprod Biomed"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114663_b0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114663_b0025","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"10.1016\/j.ejogrb.2025.114663_b0030","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/j.ejogrb.2025.114663_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.838236","article-title":"Agonist triggering in oocyte donation programs-mini review","volume":"13","author":"Najdecki","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114663_b0040","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.fertnstert.2008.03.077","article-title":"No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles","volume":"91","author":"Hern\u00e1ndez","year":"2009","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114663_b0045","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/humrep\/deg302","article-title":"Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent!","volume":"18","author":"Kol","year":"2003","journal-title":"Hum Reprod"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.114663_b0050","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/oxfordjournals.humrep.a019339","article-title":"Ovarian hyperstimulation syndrome after using onadotrophin-releasing hormone analogue as a trigger of ovulation: causes and implications","volume":"11","author":"Kol","year":"1996","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114663_b0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/deh613","article-title":"Can we eliminate severe ovarian hyperstimulation syndrome?","volume":"20","author":"Orvieto","year":"2005","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114663_b0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0015-0282(16)54474-4","article-title":"Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist","volume":"56","author":"Itskovitz","year":"1991","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114663_b0065","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1210\/jcem-57-4-792","article-title":"Hormonal dynamics at midcycle: a reevaluation*","volume":"57","author":"Hoff","year":"1983","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114663_b0070","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jcem.87.2.8197","article-title":"Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization","volume":"87","author":"Fauser","year":"2002","journal-title":"J Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114663_b0075","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.fertnstert.2010.09.009","article-title":"Efficacy of induced luteinizing hormone surge after \u201ctrigger\u201d with gonadotropin-releasing hormone agonist","volume":"95","author":"Shapiro","year":"2011","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114663_b0080","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/humrep\/des049","article-title":"Circulating luteinizing hormone level after triggering oocyte maturation with GnRH agonist may predict oocyte yield in flexible GnRH antagonist protocol","volume":"27","author":"Chen","year":"2012","journal-title":"Hum Reprod"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114663_b0085","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.jogc.2018.01.032","article-title":"Measurement of luteinizing hormone level after gonadotropin-releasing hormone agonist trigger is not useful for predicting oocyte maturity","volume":"40","author":"Dunne","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ejogrb.2025.114663_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.537205","article-title":"Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and kisspeptin during IVF treatment","volume":"11","author":"Abbara","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114663_b0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10815-021-02359-y","article-title":"Prediction, assessment, and management of suboptimal GnRH agonist trigger: a systematic review","volume":"39","author":"Ganer Herman","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.ejogrb.2025.114663_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejogrb.2024.01.022","article-title":"No association between LH levels and ovarian response in oocyte donors triggered with gonadotropin-releasing hormone agonist: a prospective study","volume":"294","author":"Blazquez","year":"2024","journal-title":"Eur J Obstet GynecolReprod Biol"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114663_b0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/jhrs.JHRS_102_17","article-title":"Repeat dose of gonadotropin-releasing hormone agonist trigger in polycystic ovarian syndrome undergoing in vitro fertilization cycles provides a better cycle outcome - a proof-of-concept study","volume":"10","author":"Deepika","year":"2017","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114663_b0110","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114663_b0115","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"19","author":"Sun","year":"2021","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114663_b0120","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/humrep\/dez132","article-title":"Predicting suboptimal oocyte yield following GnRH agonist trigger by measuring serum LH at the start of ovarian stimulation","volume":"34","author":"Popovic-Todorovic","year":"2019","journal-title":"Hum Reprod"},{"issue":"14","key":"10.1016\/j.ejogrb.2025.114663_b0125","article-title":"The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger","volume":"7","author":"Lee","year":"2023","journal-title":"Front Endocrinol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152500939X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152500939X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:24:55Z","timestamp":1760365495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152500939X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":25,"alternative-id":["S030121152500939X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114663","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.05.28.25328348","asserted-by":"object"}]},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of serum luteinising hormone concentrations post GnRH agonist trigger on metaphase II oocytes in IVF\/ICSI cycles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114663"}}